NDC 52817-291

Oxazepam

Oxazepam

Oxazepam is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Trupharma, Llc. The primary component is Oxazepam.

Product ID52817-291_0bb751ed-e01b-4fe6-bde4-511bfd3aebbc
NDC52817-291
Product TypeHuman Prescription Drug
Proprietary NameOxazepam
Generic NameOxazepam
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-05-15
Marketing CategoryANDA / ANDA
Application NumberANDA071026
Labeler NameTruPharma, LLC
Substance NameOXAZEPAM
Active Ingredient Strength15 mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 52817-291-10

100 CAPSULE in 1 BOTTLE (52817-291-10)
Marketing Start Date2020-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52817-291-10 [52817029110]

Oxazepam CAPSULE
Marketing CategoryANDA
Application NumberANDA071026
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-15

Drug Details

Active Ingredients

IngredientStrength
OXAZEPAM15 mg/1

Pharmacological Class

  • Benzodiazepine [EPC]
  • Benzodiazepines [CS]

NDC Crossover Matching brand name "Oxazepam" or generic name "Oxazepam"

NDCBrand NameGeneric Name
0228-2067OxazepamOxazepam
0228-2069OxazepamOxazepam
0228-2073OxazepamOxazepam
0781-2809OxazepamOxazepam
0781-2810OxazepamOxazepam
0781-2811OxazepamOxazepam
43353-074OxazepamOxazepam
43353-965OxazepamOxazepam
43353-980OxazepamOxazepam
52817-290OxazepamOxazepam
52817-291OxazepamOxazepam
52817-292OxazepamOxazepam
62584-812OxazepamOxazepam
62584-813OxazepamOxazepam
62584-814OxazepamOxazepam
67544-294OxazepamOxazepam
67544-117OxazepamOxazepam
67544-268OxazepamOxazepam
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.